Clinical Trials
3
Active:1
Completed:0
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)The Purpose of This Study is to Evaluate the Safety and Efficacy of D-MNA in Adult Patients With Nodular Basal Cell Carcinoma
Phase 2
Recruiting
- Conditions
- Nodular Basal Cell Carcinoma
- Interventions
- Drug: D-MNA 200 mcgDrug: D-MNA 100 mcgOther: Placebo
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2024-09-23
- Lead Sponsor
- SkinJect, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06608238
- Locations
- 🇺🇸
Site #4, Fresno, California, United States
🇺🇸Site #6, San Diego, California, United States
🇺🇸Site #1, Rolling Meadows, Illinois, United States
Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II)
Phase 1
Active, not recruiting
- Conditions
- Basal Cell Carcinoma
- Interventions
- Combination Product: Doxorubicin-containing MNADrug: Placebo-containing MNA
- First Posted Date
- 2021-06-16
- Last Posted Date
- 2023-04-14
- Lead Sponsor
- SkinJect, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT04928222
- Locations
- 🇺🇸
Beer Dermatology, West Palm Beach, Florida, United States
🇺🇸New York and Presbyterian Hospital, New York, New York, United States
Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC)
Phase 1
Terminated
- Conditions
- Basal Cell Carcinoma
- Interventions
- Drug: 100 µg doxorubicin-containing MNADrug: Placebo-containing MNADrug: 200 µg doxorubicin-containing MNADrug: 25 µg doxorubicin-containing MNADrug: 50 µg doxorubicin-containing MNA
- First Posted Date
- 2018-08-24
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- SkinJect, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT03646188
- Locations
- 🇺🇸
The Center for Clinical and Cosmetic Research, Aventura, Florida, United States
News
No news found